John Cassidy, Cambridge Cancer Genomics

Listen here:iTunes | SoundCloud | Spotify | Stitcher. Subscribe on your favourite channel to get notified of the next episode!

In this episode of CUTalks, Shreya and Thomas talk to John Cassidy, Co-founder and CEO at Cambridge Cancer Genomics (CCG.ai), a precision AI startup transforming the ability of oncologists to provide effective, personalised cancer treatment for everyone. John holds a PhD in functional genomics from the University of Cambridge and a Masters in Pharmacology from the University of Glasgow. His research career in academia (CRUK) and industry (MedImmune) focused on understanding how tumours evolve and become resistant to treatment. John is actively involved in the biotech startup community as a Venture Partner at the Pioneer Fund, Director of SiliconBio and a lecturer at Anglia Ruskin University. 

This episode was sponsored by DesignSpark: design tools and resources for engineers to help make their ideas happen. The podcast was produced by Carl Homer, Cambridge TV.

Jump to the following topics:

  1. Introduction to CCG - 1:20 

  2. How CCG evolves over the years, from Cambridge to California - 2:40

  3. Lessons learned throughout John’s journey as a CEO - 5:30

  4. How CCG works with clinicians - 11:00

  5. CCG’s data governance policies - 13:00

  6. How to manage relationships with various stakeholders - 16:00

  7. Advice for aspiring entrepreneurs - 18:00

  8. The nature of customer acquisition in medtech - 19:00

  9. Dealing with NHS and the global market beyond - 20:20

  10. CCG’s milestones - 24:00

  11. How to raise investment in medtech - 25:10

  12. CCG’s value differentiators - 26:50

  13. The reason CCG chooses Cambridge - 29:30

CUTECComment